Salarius Pharmaceuticals Files 2024 10-K
Ticker: DCOY · Form: 10-K · Filed: Mar 21, 2025 · CIK: 1615219
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, financials
TL;DR
Salarius Pharma dropped its 2024 10-K. Financials for 2022-2024 are in. Check it out.
AI Summary
Salarius Pharmaceuticals, Inc. filed its 2024 10-K on March 21, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, previously known as Flex Pharma, Inc., is based in Houston, TX, and operates in the pharmaceutical preparations sector. The filing provides financial data for the years 2022, 2023, and 2024, including common stock, additional paid-in capital, and retained earnings.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Salarius Pharmaceuticals' financial health and operational status for the fiscal year 2024, crucial for understanding the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Salarius Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-21 — Filing Date (The date the 10-K was submitted to the SEC.)
- 2022, 2023, 2024 — Financial Years Reported (The company provided financial data for these three years.)
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Filer of the 10-K
- Flex Pharma, Inc. (company) — Former name of Salarius Pharmaceuticals
- 2024-12-31 (date) — Fiscal year end
- 2025-03-21 (date) — Filing date
- Houston, TX (location) — Company headquarters
FAQ
What were Salarius Pharmaceuticals' key financial figures for common stock, additional paid-in capital, and retained earnings for the fiscal years 2022, 2023, and 2024?
The filing indicates that financial data for common stock, additional paid-in capital, and retained earnings were reported for the periods ending December 31, 2022, 2023, and 2024.
When was Salarius Pharmaceuticals previously known by another name?
Salarius Pharmaceuticals, Inc. was formerly known as Flex Pharma, Inc., with a name change occurring on July 30, 2014.
What is the Standard Industrial Classification (SIC) code for Salarius Pharmaceuticals?
The SIC code for Salarius Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Where is Salarius Pharmaceuticals headquartered?
Salarius Pharmaceuticals, Inc. is headquartered in Houston, TX, with its business and mailing addresses listed at 2450 Holcombe Blvd, Suite J-608.
What is the SEC file number for Salarius Pharmaceuticals' 10-K filing?
The SEC file number for Salarius Pharmaceuticals' 10-K filing is 001-36812.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 21, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).